Diagnostic Imaging spoke with Dr. Johnsey Leef III, a radiologist with Charleston Area Medical Center in Charleston, WV, about how the industry is responding to the call for lower dose imaging and what his department is doing to address the issue.
[[{"type":"media","view_mode":"media_crop","fid":"11552","attributes":{"alt":"Johnsey Leef III","class":"media-image media-image-left","id":"media_crop_7278503878259","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"219","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]Diagnostic Imaging spoke with Dr. Johnsey Leef III, a radiologist with Charleston Area Medical Center in Charleston, WV, about how the industry is responding to the call for lower dose imaging and what his department is doing to address the issue.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.